Evidence map›Paper›PMID 38751383›Full record

ReviewExploration of targeted anti-tumor therapy2024

Improving the quality of patient care in lung cancer: key factors for successful multidisciplinary team working.

Alessandro Morabito, Edoardo Mercadante, Paolo Muto, Anna Manzo, Giuliano Palumbo, Vincenzo Sforza, Agnese Montanino, Claudia Sandomenico, Raffaele Costanzo, Giovanna Esposito and 10 more

Abstract readReview
In one paragraph

Review in Exploration of targeted anti-tumor therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Malignant Pleural Mesothelioma CT Imaging: How to Measure It Correctly?Cancer control : journal of the Moffitt Cancer Center
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alessandro MorabitoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-1319-9608
Edoardo MercadanteThoracic Surgery, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0003-2101-1254
Paolo MutoRadiotherapy, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-7546-6441
Anna ManzoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-9608-8865
Giuliano PalumboThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-1843-622X
Vincenzo SforzaThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0001-7828-3854
Agnese MontaninoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0003-4271-8275
Claudia SandomenicoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0003-3709-0807
Raffaele CostanzoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0001-9108-5609
Giovanna EspositoThoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0001-6238-1556
Giuseppe TotaroRadiotherapy, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-3412-4568
Rossella De CecioPathology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0001-9779-7076
Carmine PiconeRadiology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-5344-0056
Annamaria PortoRadiology, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-5575-4809
Nicola NormannoCellular Biology and Biotherapy, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-7158-2605
Arturo CapassoWSB Merito University in Wroclaw, Fabryczna 29-31, 53-609 Wroclaw, Poland.ORCID https://orcid.org/0000-0002-1379-3009
Monica PintoRehabilitative Medicine Unit, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-0823-4907
Maura TraceyRehabilitative Medicine Unit, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0003-1561-4796
Giuseppe CaropresoDivision of Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80131 Naples, Italy.ORCID https://orcid.org/0009-0005-8565-3610
Giacomo PascarellaScientific Directorate, Istituto Nazionale Tumori, IRCCS "Fondazione G. Pascale", 80131 Naples, Italy.ORCID https://orcid.org/0000-0002-6458-6106

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

International Guidelines as well as Cancer Associations recommend a multidisciplinary approach to lung cancer care. A multidisciplinary team (MDT) can significantly improve treatment decision-making and patient coordination by putting different physicians and other health professionals "in the same room", who collectively decide upon the best possible treatment. However, this is not a panacea for cancer treatment. The impact of multidisciplinary care (MDC) on patient outcomes is not univocal, while the effective functioning of the MDT depends on many factors. This review presents the available MDT literature with an emphasis on the key factors that characterize high-quality patient care in lung cancer. The study was conducted with a bibliographic search using different electronic databases (PubMed Central, Scopus, Google Scholar, and Google) referring to multidisciplinary cancer care settings. Many key elements appear consolidated, while others emerge as prevalent and actual, especially those related to visible barriers which work across geographic, organizational, and disciplinary boundaries. MDTs must be sustained by strategic management, structured within the entity, and cannot be managed as a separate care process. Furthermore, they need to coordinate with other teams (within and outside the organization) and join with the broad range of services delivered by multiple providers at various points of the cancer journey or within the system, with the vision of integrated care.

Indexed as

care pathwaymultidisciplinary clinic modelMultidisciplinary team caremulti-team system

Identifiers

PMID38751383
PMCPMC11093720

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.